Vector Science and Therapeutics (PAIN) Stock Overview
Develops and sells novel biomechanical devices and active localized drug-delivery platforms. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
PAIN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Vector Science and Therapeutics Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.64 |
| 52 Week High | CA$2.65 |
| 52 Week Low | CA$0.35 |
| Beta | 4.65 |
| 1 Month Change | -32.51% |
| 3 Month Change | 164.52% |
| 1 Year Change | n/a |
| 3 Year Change | 2,633.33% |
| 5 Year Change | n/a |
| Change since IPO | 556.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| PAIN | CA Biotechs | CA Market | |
|---|---|---|---|
| 7D | 2.5% | 5.0% | 0.7% |
| 1Y | n/a | 27.3% | 30.5% |
Return vs Industry: Insufficient data to determine how PAIN performed against the Canadian Biotechs industry.
Return vs Market: Insufficient data to determine how PAIN performed against the Canadian Market.
Price Volatility
| PAIN volatility | |
|---|---|
| PAIN Average Weekly Movement | 14.6% |
| Biotechs Industry Average Movement | 9.6% |
| Market Average Movement | 9.5% |
| 10% most volatile stocks in CA Market | 16.3% |
| 10% least volatile stocks in CA Market | 3.7% |
Stable Share Price: PAIN's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: Insufficient data to determine PAIN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Bill Jackson | vectorscience.co |
Vector Science and Therapeutics Corp. develops and sells novel biomechanical devices and active localized drug-delivery platforms. The company offers products and services based on its Smart, Steered, and Sustained framework for site-directed interventions in musculoskeletal tissue regeneration. The company has a development and manufacturing agreement with MPP Group LLC to develop and manufacture pharmaceutical-grade peptides and drug delivery devices.
Vector Science and Therapeutics Corp. Fundamentals Summary
| PAIN fundamental statistics | |
|---|---|
| Market cap | CA$251.75m |
| Earnings (TTM) | -CA$1.26m |
| Revenue (TTM) | n/a |
Is PAIN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PAIN income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$150.05k |
| Gross Profit | -US$150.05k |
| Other Expenses | US$747.96k |
| Earnings | -US$898.01k |
Last Reported Earnings
Aug 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0057 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did PAIN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/04 04:20 |
| End of Day Share Price | 2026/08/04 00:00 |
| Earnings | 2025/08/31 |
| Annual Earnings | 2025/08/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Vector Science and Therapeutics Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.